Company Johnson & Johnson

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 00:00:02 14/02/2026 +03			5-day change	1st Jan Change
243.45 ^USD	-0.45%		+1.44%	+17.64%

02-13	Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial	RE
02-13	Pennsylvania jury finds Johnson & Johnson liable for woman's ovarian cancer - attorney for national talc plaintiffs	RE

Business description: Johnson & Johnson

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

At the end of 2024, Johnson & Johnson has 64 manufacturing facilities located in the United States (23), North America (7), Europe (21), Africa and Asia/Pacific (13).

The United States accounts for 56.6% of net sales.

Number of employees: 138,100

Sales by Activity: Johnson & Johnson

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Innovative Medicine	45.57B	52.08B	52.56B	54.76B	56.96B
Medtech	22.96B	27.06B	27.43B	30.4B	31.86B
Consumer Health	14.05B	14.64B	14.95B	-	-

See all business segments

Geographical breakdown of sales: Johnson & Johnson

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
United States	43.13B	47.16B	48.58B	46.44B	50.3B
Europe	18.98B	23.59B	23.45B	20.41B	20.21B
Asia-Pacific, Africa	15.14B	17.28B	16.79B	13.76B	13.59B
Western Hemisphere, Excluding U.S.	5.34B	5.75B	6.12B	4.55B	4.71B

See all geographic segments

Executive Committee: Johnson & Johnson

Manager	Title	Age	Since
Joaquin Duato CEO	Chief Executive Officer	63	03/01/2022
Joseph Wolk DFI	Director of Finance/CFO	59	01/07/2018
Penny M. Heaton CTO	Chief Tech/Sci/R&D Officer	61	01/08/2024
Kathryn Wengel CTO	Chief Tech/Sci/R&D Officer	60	01/01/2023
James Swanson CTO	Chief Tech/Sci/R&D Officer	60	05/11/2019

See JOHNSON & JOHNSON governance

Composition of the Board of Directors: Johnson & Johnson

Director	Title	Age	Since
Anne Mulcahy BRD	Director/Board Member	72	23/10/2009
Mark McClellan BRD	Director/Board Member	62	15/10/2013
Mary Beckerle BRD	Director/Board Member	71	09/06/2015
Joaquin Duato CHM	Chairman	63	02/01/2023
Jennifer Doudna BRD	Director/Board Member	62	13/02/2018
Marillyn Hewson BRD	Director/Board Member	72	25/04/2019
Hubert Joly BRD	Director/Board Member	66	05/12/2019
Mark Weinberger BRD	Director/Board Member	64	05/12/2019
Nadja West BRD	Director/Board Member	65	03/12/2020
Paula Johnson BRD	Director/Board Member	66	14/02/2023

Composition of the Board of Directors

Shareholders: Johnson & Johnson

Name	Equities	%	Valuation
The Vanguard Group, Inc. 10.1 %	243,455,135	10.1 %	55 325 M $
Vanguard Fiduciary Trust Co. 9.976 %	240,349,660	9.976 %	54 619 M $
BlackRock Advisors LLC 6.475 %	156,007,213	6.475 %	35 453 M $
STATE STREET CORPORATION 5.487 %	132,206,061	5.487 %	30 044 M $
JPMorgan Investment Management, Inc. 2.434 %	58,639,437	2.434 %	13 326 M $

Name	Equities	%	Valuation
Itaú Unibanco Asset Management Ltda. 0.00051 %	184,357	0.00051 %	3 M $
Morgan Stanley Administradora de Carteiras SA 0 %	51	0 %	776 $

List of JOHNSON & JOHNSON shareholders

Holdings: Johnson & Johnson

Name	Equities	%	Valuation
IDORSIA LTD 3.82%	9,581,882	3.82%	45 M $
CRYO-CELL INTERNATIONAL, INC. 2.72%	219,139	2.72%	727 541 $

Company details: Johnson & Johnson

Johnson & Johnson

One Johnson & Johnson Plaza

08933, New Brunswick

+732 524 0400

http://www.jnj.com

Group companies: Johnson & Johnson

Name	Category and Sector
Synthes, Inc. (Pennsylvania) Synthes, Inc. (Pennsylvania) Medical/Nursing ServicesHealth Services Provides medical products	Medical/Nursing Services
ABIOMED Europe GmbH ABIOMED Europe GmbH Medical SpecialtiesHealth Technology Manufactures and markets micro blood pumps	Medical Specialties
Synthes Holding AG Synthes Holding AG MiscellaneousMiscellaneous Functions as an investment holding company	Miscellaneous
Johnson & Johnson de Chile SA Johnson & Johnson de Chile SA Manufactures pharmaceutical and health care products
Johnson & Johnson de México SA de CV Johnson & Johnson de México SA de CV Medical DistributorsDistribution Services Distributes healthcare and personal care products	Medical Distributors

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
JOHNSON & JOHNSON	-0.45%	+1.44%	+54.82%	+49.59%	587B
ELI LILLY AND COMPANY	+0.33%	-1.72%	+19.29%	+196.80%	929B
ABBVIE INC.	+1.76%	+3.61%	+19.67%	+50.59%	409B
ROCHE HOLDING AG	+0.08%	+1.01%	+20.89%	+28.94%	374B
ASTRAZENECA PLC	+1.42%	+7.19%	+26.36%	+32.36%	320B
NOVARTIS AG	+1.08%	+4.32%	+27.98%	+55.61%	311B
MERCK & CO., INC.	+1.82%	-0.43%	+43.82%	+10.83%	301B
NOVO NORDISK A/S	+1.32%	+5.11%	-45.12%	-37.51%	219B
AMGEN INC.	+1.52%	-3.94%	+24.32%	+51.52%	199B
GILEAD SCIENCES, INC.	+2.09%	+1.63%	+46.26%	+77.14%	192B
Average	+1.10%	+1.96%	+23.83%	+51.59%	384.09B
Weighted average by Cap.	+0.81%	+1.58%	+26.06%	+75.81%